How Cannabis Legalization Shapes Cancer Survivorship Care in Canada
Research Summary by Truong M. Nguyen, Science Officer in RnD
Research Published: 26 January 2026
In October 2018, Canada legalized non-medical Cannabis, expanding nationwide access outside the formal medical system. This policy shift created a unique opportunity to examine how individuals, including those living with or beyond cancer, make decisions about using Cannabis for symptom management and quality of life.
This study explored how people evaluate Cannabis use when it is legally available but still shaped by social, medical, and cultural factors.
Methods: How the Study Was Conducted
Researchers surveyed 1,089 Canadian adults using a discrete choice experiment. Participants were asked to evaluate Cannabis based on several factors, including:
Symptom relief
Ability to maintain daily functioning
Potential side effects
Ease of access
Cost
Social opinion
Physician opinion
Most participants had no cancer history, while over one-third had prior experience using Cannabis.
Key Findings: What Matters Most to Patients
Top Priorities
Participants ranked the following as the most important factors influencing their decisions:
Effective relief of cancer-related symptoms
Ability to carry out everyday activities and maintain quality of life
Fewer unwanted side effects
Lower Priorities
Social and physician opinions were consistently rated as less influential than personal well-being and functional outcomes.
This suggests that patients prioritize how they feel and function over external approval or institutional guidance.
Stigma Persists Despite Legalization
Even under full legalization, many individuals living with cancer reported ongoing feelings of fear, shame, or discomfort related to Cannabis use.
Key insights included:
Decades of stigma continue to shape patient behavior.
Some individuals prefer non-medical access to manage symptoms privately.
Anonymous access allows patients to avoid judgment, discrimination, or unwanted disclosure within healthcare settings.
Legal status alone does not eliminate social or medical stigma.
Interpretation Through the Endocannabinoid System (ECS)
These findings align closely with the biological role of the Endocannabinoid System, a regulatory system involved in pain, inflammation, mood, sleep, appetite, immune function, and overall physiological balance.
Patients are not seeking intoxication. They are seeking regulation, stability, and symptom relief, which are core functions of the ECS. The consistent emphasis on daily functioning and quality of life reflects the ECS’s foundational role in maintaining internal balance, particularly during chronic illness and cancer recovery.
Why This Matters for Cancer Survivorship Care
This research highlights a growing disconnect between patient behavior and healthcare systems:
Cancer survivors prioritize dignity, autonomy, and symptom control.
Many feel safer self-navigating Cannabis use than discussing it with providers.
This reveals gaps in survivorship care, clinical education, and patient–provider trust.
Survivorship care models have not yet fully integrated ECS science or cannabinoid therapies, despite growing evidence and widespread patient use.
Policy & Care Implications
Despite increasing evidence supporting the safety and therapeutic potential of Cannabis, it remains under-integrated into formal cancer care models.
Legacy drug policies continue to influence stigma, access, and disclosure. As a result, patients are often forced to manage their care independently rather than within supportive, informed medical environments.
To align healthcare with real-world patient needs, survivorship care must evolve to include:
ECS education for healthcare professionals
Evidence-based cannabinoid care models
Patient-centered policies that prioritize dignity and quality of life
Author Perspective
The following commentary is provided by the contributing author and reflects their personal perspective on drug policy and survivorship care.
It’s wrong when the Use of natural plant products, proven safe and effective to reduce and Eliminate Horrific Symptoms and Adverse Effects of Cancer and its traditional Treatments, while Showing Potential to Suppress Various Cancer Cells, needs to be hidden from View.
All wars leave deep, lasting scars even after peace prevails.
Unfortunately, we are still at War with Drugs (Bad Policies) with continued harm inflicted on society’s most vulnerable, and creating many man-made problems.
This failed expensive global social experiment/project to change human nature and rights to self-determination and choose what we want to consume is absolutely wrong and needs immediate intervention.
Bottom Line
Cannabis improves quality of life for many individuals living with and beyond cancer. However, persistent stigma and outdated systems continue to drive patients toward anonymous access and self-guided care.
This research reinforces the need to update cancer survivorship models to reflect lived experience, biological reality, and the central role of the Endocannabinoid System in human health.
Note from EC Newsletter Team
If you are looking for support or guidance and do not know where to start, feel free to reach out to [email protected], and we will be happy to point you in the right direction. Below are a few resources you may find helpful.
About Truong M. Nguyen
Truong M. Nguyen is a Science Officer in RnD at Green Culture Labs LTD, working at the intersection of pharmaceutical research, regulatory science, and botanical medicine. Through collaborations with Thailand’s Ministry of Public Health, Ministry of Mental Health, and the Thai Traditional Medicines Society, he supports the development of pharmaceutical-grade Cannabis and other plant-derived therapies. His work emphasizes safety, efficacy, and expanding access through internationally aligned regulatory frameworks.
Click the Learn More Button
